Astragaloside IV reduces cardiomyocyte apoptosis in a murine model of coxsackievirus B3-induced viral myocarditis
Open Access
- 1 January 2019
- journal article
- research article
- Published by Japanese Association for Laboratory Animal Science in Experimental Animals
- Vol. 68 (4) , 549-558
Abstract
Apoptosis plays a crucial role in regulating cardiomyopathy and injuries of coxsackievirus B3 (CVB3)-induced viral myocarditis (VM). It has been reported that Astragaloside IV (AST-IV) from Astragalus membranaceus could inhibit apoptosis under a variety of pathological conditions in vivo or in vitro. However, the functional roles of AST-IV in CVB3-induced VM still remain unknown. Here, we found that AST-IV significantly enhanced survival for CVB3-induced mice. AST-IV protected the mice against CVB3-induced virus myocarditis characterized by the increased body weight, decreased serum level of creatine kinase-MB (CK-MB) and lactate dehydrogenase (LDH), supressed expression of Ifn-γ, Il-6 in heart, enhanced systolic and diastolic function of left ventricle. At the pathological level, AST-IV ameliorated the mice against CVB3-induced myocardial damage and myocardial fibrosis. In vitro, the results from flow cytometry showed that AST-IV significantly suppressed CVB3-induced cardiomyocytes apoptosis, which also were verified in vivo. Moreover, an increased expression of pro-apoptotic genes including FAS, FASL, cleaved caspase-8 and cleaved caspase-3 was found in CVB3-induced cardiomyocytes, while those was inhibited in cardiomyocytes treated with AST-IV. Taken together, the data suggest that AST-IV protected against CVB3-induced myocardial damage and fibrosis, which may partly attribute to supress activation of FAS/FASL signaling pathway.Keywords
This publication has 45 references indexed in Scilit:
- Targeted disruption of Hspa4 gene leads to cardiac hypertrophy and fibrosisJournal of Molecular and Cellular Cardiology, 2012
- The Emerging Role of Innate Immunity in the Heart and Vascular SystemCirculation Research, 2011
- Virus serology in patients with suspected myocarditis: utility or futility?European Heart Journal, 2011
- Mesenchymal stem cells improve murine acute coxsackievirus B3-induced myocarditisEuropean Heart Journal, 2010
- Overexpressed Exogenous IL-4 And IL-10 Paradoxically Regulate Allogenic T-Cell and Cardiac Myocytes Apoptosis Through FAS/FASL PathwayTransplantation, 2008
- Effect of astragaloside on cardiomyocyte apoptosis in murine coxsackievirus B3myocarditisJournal of Asian Natural Products Research, 2007
- Role of the JAK–STAT pathway in myocardial injuryTrends in Molecular Medicine, 2007
- Astragaloside IV Exerts Antiviral Effects Against Coxsackievirus B3 by Upregulating Interferon-??Journal of Cardiovascular Pharmacology, 2006
- Postinfarction Gene Therapy Against Transforming Growth Factor-β Signal Modulates Infarct Tissue Dynamics and Attenuates Left Ventricular Remodeling and Heart FailureCirculation, 2005
- Overexpression of Human Copper/Zinc Superoxide Dismutase (SOD1) Suppresses Ischemia–Reperfusion Injury and Subsequent Development of Graft Coronary Artery Disease in Murine Cardiac GraftsCirculation, 2004